The major shareholder Zhang Ming of SOUTH MANGANESE (01091) sold a total of 535 million shares of the company.
(01091) released an announcement regarding Mr. Zhang Ming, the company's major shareholder, submitting a disclosure notice of his equity related to the disposal of his shares on January 28, 2026. On that day, Mr. Zhang sold a total of 535 million shares of the company, equivalent to approximately 10.83% of the total issued shares of the company, at an average selling price of HK$0.24 per share. Following the completion of the disposal, Mr. Zhang no longer holds any shares and is no longer a major shareholder of the company.
SOUTH MANGANESE (01091) announces that Mr. Zhang Ming, a major shareholder of the company, has submitted a disclosure notice regarding the sale of his shares in the company on January 28, 2026. On that day, Mr. Zhang sold a total of 535 million shares of the company, equivalent to approximately 10.83% of the total issued shares of the company, at an average selling price of HK$0.24 per share (the "sale"). Following the completion of the sale, Mr. Zhang no longer holds any shares and is no longer a major shareholder of the company.
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


